Navigation Links
Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
Date:11/1/2011

exchange rate changes on cash and cash equivalents(0.7)(0.5)Net (decrease) increase in cash and cash equivalents(119.5)54.2Cash and cash equivalents at beginning of period282.8201.4Cash and cash equivalents at end of period$
3.3$
255.6The following table presents a reconciliation of reported net income and diluted earnings per share to non-GAAP net income for the three and nine months ended September 30, 2011 and 2010:Table 4Watson Pharmaceuticals, Inc.Reconciliation Table(Unaudited; in millions except per share amounts)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010GAAP to non-GAAP net income calculationReported GAAP net income attributable to
 common shareholders$
8.1$
25.7$
.1$
.1Adjusted for:Amortization72.045.9204.0128.0Global supply chain initiative(1)3.39.015.129.7Acquisition and licensing charges9.52.422.923.8Interest accretion on contingent liabilities10.88.229.721.6Non-cash impairment charges3.80.125.61.2Non-recurring (gains) losses(5.1)(12.2)(24.8)Legal settlements-89.9-92.9Income taxes on items above(23.7)(75.3)(72.7)(129.6)Non-GAAP net income attributable to
 common shareholders$
38.7$
5.9$
378.5$
308.9Diluted earnings per share Diluted earnings per share - GAAP $
.54$
.21$
.31$
.34Diluted earnings per share - Non-GAAP$
.09$
.85$
2.99$
2.49Basic weighted average common shares outstanding124.9122.6124.4122.2Effect of dilutive securities:   Dilutive share-based compensation arrangements2.01.72.01.7Diluted weighted average common shares outstanding126.9124.3126.4123.9(1)

Includes accelerated depreciation charges.The following table presents a reconciliation of reported net income to adjusted EBITDA for the three and nine months ended September 30, 2011 and 2010:

Table 5Watson Pharmaceuticals, Inc.Adjusted EBITDA Reconciliation Table(Unaudited; in millions)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010G
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
2. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
3. Watson Confirms Daytrana(R) Patent Challenge
4. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
5. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
6. Watson Confirms EMBEDA(R) Patent Challenge
7. Watson Launches Generic FEMCON(R) Fe
8. Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings
9. Watson to Present at the Jefferies 2011 Global Healthcare Conference
10. Watson Confirms Amphastar Patent Lawsuit
11. Watson Pharmaceuticals Announces Approval of Amphastars Generic LOVENOX(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has ... (Bayer) to develop and commercialize ISIS-FXI Rx for ... agreement, Isis is eligible to receive up to $155 ... up-front payment and a $55 million payment upon advancement ... patients with compromised kidney function. Isis is also eligible ...
(Date:5/4/2015)... , May 4, 2015  FireflySci Inc., the newest member of the cuvette manufacturing ... they have turned the cuvette industry on its head by offering scientists amazing support for their ... Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3
... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... with operations in China and the United States, today ... second quarter of 2011 after the New York Stock ... be Thursday morning, August 11, 2011 Shanghai time). The ...
... RAPIDS, Mich., July 19, 2011 ... rehabilitation and software services that benefit patients, healthcare ... to its multi-state group of outpatient clinics.  Agility ... the Company,s Michigan-based outpatient clinic presence to 23 ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2Agility Health Expands National Outpatient Clinic Group with New Michigan Facility 2
(Date:5/4/2015)... 2015 Leonardo J. Lozada, M.D., Saint ... executive, and William C. Daniel, M.D., Saint Luke’s Health ... invitations from the Secretary of the Air Force to ... the Air War College, Maxwell Air Force Base, Alabama. ... to senior U.S. and international officers and their civilian ...
(Date:5/4/2015)... New York (PRWEB) May 04, 2015 ... as $2.4 billion to settle thousands of Actos lawsuits ... diabetes medication increases the risk that a patient will ... on April 28th, if 95% of those eligible for ... resolve nearly 9,000 bladder cancer cases currently pending in ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ... center on Wednesday, April 22. , Johnson & Wales becomes ... by the re-alignment of Interstate-195. JWU’s new academic building, which ... streets in Providence, is scheduled to be completed in July ... the university purchased in 2012. , “It has long been ...
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
(Date:5/4/2015)... May 04, 2015 METTLER TOLEDO ... Importance of Data Integrity in a GXP Regulated ... guest presenter. This webinar will be presented on ... , Data integrity is a critical component of ... regulatory agencies. However, in recent years an increasing ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2
... spot teens prone to violence , , SATURDAY, Aug. 18 ... down fellow students in the hallways or grounds of ... This is an extreme form of shyness affecting mostly ... that seen at Columbine, Colo., or, most recently, Virginia ...
... found , FRIDAY, Aug. 17 (HealthDay News) -- Dirty ... pointing to heart risk in young adults, a Taiwanese ... oxidative stress, and blood coagulation, according to the study, ... Journal of Respiratory and Critical Care Medicine . , ...
... is 10th leading killer in United States, experts say ... they appear clinically similar, patients with potentially deadly sepsis ... U.S. researchers who conducted the first large-scale natural history ... result of the body,s inflammatory response to infection -- ...
... study finds , , FRIDAY, Aug. 17 (HealthDay News) -- Depression ... returning from duty in Iraq or Afghanistan, placing a tremendous ... , Researchers studied the home life of 168 soldiers diagnosed ... half -- 42 percent -- of these veterans said they ...
... quickly, raising chance of morphine overdose for baby , , ... use medicines containing codeine and metabolize the drug quickly ... morphine overdose, U.S. health officials said Friday. , ... by a report of the death of a 13-day-old ...
... trouble in September, experts say , , FRIDAY, Aug. ... that establishing regular sleep habits should be included on ... their sleep schedules about two weeks prior to the ... National Sleep Foundation. Children need adequate sleep in order ...
Cached Medicine News:Health News:Does Pathological Shyness Make for School Shooters? 2Health News:Does Pathological Shyness Make for School Shooters? 3Health News:Does Pathological Shyness Make for School Shooters? 4Health News:Urban Smog Tough on Young Adults' Hearts 2Health News:Scientists Probe Sepsis' Deadly Secrets 2Health News:Depression Taking Toll on Returning U.S. Vets 2Health News:Depression Taking Toll on Returning U.S. Vets 3Health News:Depression Taking Toll on Returning U.S. Vets 4Health News:FDA Warns of Codeine Risk for Some Nursing Mothers 2Health News:FDA Warns of Codeine Risk for Some Nursing Mothers 3Health News:Time to Set Kids' Back-to-School Sleep Clocks 2
Inquire...
... • V-shaped bottom allows easy ... or 5 per bag ,• Corner ... Pipettor Solution Basin designed for 4, 8, ... V-shaped bottom permits withdrawal of practically all ...
... Calibration Software monitors and documents the accuracy ... entire operating life. This new program was ... from gravimetric or photometric pipette tests. It ... types from various manufacturers and other liquid ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: